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Abstract
Ion channels are transmembrane proteins, found in virtually all cell types 
throughout the human body. Ion channels underlie neural communication, 
memory, behavior, every movement and heartbeat, and are as such prone to 
cause disease if malfunctioning. Therefore ion channels are very important 
targets in drug discovery. The gold standard technique for obtaining information 
on ion channel function with high information content and temporal resolution is 
patch-clamp. The technique measures the minute currents originating from the 
movement of ions across the cellular membrane, and enables determination of 
the potency and efficacy of a drug. However, patch-clamp suffers from serious 
throughput restrictions due to its laborious nature. To address the throughput 
problems we have developed a microfluidic chip containing 48 microchannels 
for an extremely rapid, sequential delivery of a large number of completely 
controlled solution environments to a lifted, patch-clamped cell. In this way, 
throughput is increased drastically compared to classical patch-clamp perfusion 
set-ups, with uncompromised data quality. The 48-microchannel chip has been 
used for the characterization of drugs affecting ligand-gated ion channels 
including agonists, antagonists and positive modulators with positive effects on 
both throughput and data quality.
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Introduction
Ion channels are of central importance in the body. They serve as conduits 
between the inside of cells and the outside world, controlling basic bodily 
processes such as heartbeats, metabolism and immunity as well as more complex 
processes such as emotions, learning and memory (1). Increasing evidence 
indicates that the direct or indirect malfunctioning of an ion channel can severely 
affect human health and many ion channels are thus considered to be important 
therapeutic targets (2). The standard technique for acquiring high-information 
content functional ion channel data is the patch clamp method (3). The technique 
relies on the electric clamping of the cellular membrane potential o f a single cell, 
while measuring the ionic current caused by ion channel activity. Due to the 
high temporal resolution and the sensitivity of the technique, it is possible to 
record the activity of single ion channels with sub-millisecond time resolution. 
However, acquiring high quality patch clamp data is a tedious process, requiring 
extensive work input from highly skilled operators. Due to these limitations, the 
identification of compounds that affect the desired ion channel function is 
cumbersome and time-consuming. As the need for high quality ion channel data 
continues to increase, the patch clamp technique has become the bottleneck in 
the efforts to increase productivity in the process of ion channel screening. 
Therefore, large efforts have been made in developing parallel patch clamp 
devices that aim to automate and multiplex the number o f patch-clamped cells 
and thereby increase throughput in screening applications (4-10). Although the 
automated patch clamp devices indeed offer an increased rate of compound 
testing, this improvement unfortunately comes at a price, being reduced 
recording quality, time resolution and loss of flexibility and control during the 
experiment (11). In particular, the automated patch clamp systems are not 
amenable for screening ligand-gated ion channel targets, mainly because these 
systems lack the ability for rapid and precise solution switching. Because 
activation and desensitization of many types of ligand-gated ion-channels occurs 
within a few milliseconds (1,12-14), methods are required that can change a 
large number of solutions containing different ligands around cells in the same 
time range in order to efficiently study such rapid receptor interactions. 
Examples of pharmacologically important ion channels that display fast kinetics 
are nicotinic acethylcholine receptors, controlling muscle function, and ligand- 
gated channels of fast chemical synapses such as GABA and AMPA receptors, 
involved in neuronal modulation. Consequently, the need for development of 
screening methods for ion channels that offer high throughput, low cost, fast, 
flexible and well-controlled solution exchange while still maintaining the high
information content offered by classic patch clamp screening is growing at a 
rapid pace.
Rather than resorting to a parallel patch-clamp concept, we have 
developed a system where conventional single-cell-based patch clamp technique 
is combined with chip-based microfluidics for rapid sequential delivery of ion 
channel agonists or antagonists onto patch-clamped cells (15,16). Here, we 
extend the previous findings and demonstrate a 48 channel chip facilitating 
advanced investigations o f ion channel function by utilization of complex 
substance application patterns, possibly involving a range of different substances 
to be applied to the cell sequentially. To demonstrate the functionality of this 
device we performed patch clamp recordings of several different dose response 
curves from a single cell on one chip. Furthermore, we demonstrate that the 
excellent experimental control, and solution switching properties, enables direct 
extraction of kinetic parameters from the obtained data sets.
Materials and Methods
Cell culture. The WSS-1 cell line (HEK 293 transfected with GABAa 
receptor) was used. Cells were grown adherent for 2-4 days on plastic Petri 
dishes in DMEM supplemented with antibiotics, L-glutamine, glucose (4.5g/L), 
Na-carbonate and fetal ca lf serum (10%).
Solutions and drugs. The extracellular solution used in all experiments 
contained, in mM; 140 NaCl, 5 KC1, 1 MgCl2, 1 CaCl2, 10 Hepes, 10 D- 
Glucose, pH 7,4. The electrodes were filled with intracellular solution, in mM; 
100 KC1, 2 M gCb, 1 CaCl2, 11 EGTA, 10 Hepes, pH 7.2. GABA was obtained 
from Calbiochem (La Jolla, CA) and ß-alanine and bicuculline methiodide, were 
from Sigma (St. Louis, MO).
Electrophysiology. Whole cell patch clamp methods were used in all 
experiments. Glass electrodes were fabricated from thick wall borosilicate glass 
and the resistances of the pulled patch pipettes were 3-5 MU. All data was 
recorded using an Axopatch2B (Axon Instruments) patch clamp amplifier. The 
cells were clamped at -40mV. Current signals were recorded at a sampling 
frequency o f 5 kHz, low pass filtered (1 kHz, 4-pole Bessel filter) and analyzed 
using the Clampfit8 software. Two different GABA receptor agonists (GABA 
and ß-alanine) and one antagonist (Bicuculline) were used. Every other well was 
loaded with buffer for washing interdigitated with the various concentrations of 
agonists and antagonist. GABA concentrations used was 1,5,  10, 20, 50, 100, 
and 500 цМ, ß-alanine concentrations used was 1, 5, 10, 20, 50, 100, and 500 
mM, and bicuculline concentrations of 0.01, 0.1, 1, 5, 10, and 100 /xM was 
со-applied with 100 дМ  GABA.
System  operation. The fabrication of the devices has been described in 
detail elsew here (16). The DF-48 chip is comprised of 48 sample wells 
connected to an open volume through 50x60 цт  (wxh) microchannels. At the 
exit into the open volume, the channels are tightly packed, separated by 30 [im 
wide walls. The chip was placed on a software controlled, motorized scanning 
stage mounted on an inverted microscope. A cell was patch-clamped in the open 
volume, lifted up approximately 30 /xm, and translocated to the channel outlets. 
Pressure was applied to initiate a flow corresponding to 3 min/s, and the cell was 
translocated between different solution environments and exposed to ion channel 
effectors according to a predefined experimental protocol.
Results and discussion
We present a microfluidic device designed to increase throughput in ion 
channel screening. The system is composed of a 48-well microfluidic chip, a 
motorized scanning stage, a pump for creating flow, and software to control the 
scanning actions of the motorized scanning stage. The system is easily integrated 
onto the microscope of an existing patch clamp setup (Figure 1). Due to the 
small size of the microchannels, the fluids behave in ways that differ in a 
fundamental way from macroscopic systems. The flow in the microfluidic 
device is in the low Reynolds number regime, characterized by a completely 
laminar flow, with mixing occurring only by diffusion (17). As a result of this, 
the individual channel compositions is maintained well out into the open volume 
(16). Thus, virtual microcontainers of different drug solutions are created in an 
open volume that can be accessed by a biological cell detector only a few 
microns large, e.g. a patch clamped cell. By translating a lifted, patch clamped 
cell in front of the channel outlets, solution switch times of 10-15 ms is well 
achievable. Apart from the advantages in ion channel screening, several other 
benefits are achieved by placing the patch clamped cell in the laminar flow. The 
force that the laminar fluid flow exerts on the cell-pipette system stabilizes the 
seal and produces higher seal resistances (without affecting the access 
resistances), longer recording times, and lower noise levels (18).
The system was used together with WSS-1 cells expressing the GAB Ад- 
receptor, chloride selective ion channels that become activated after binding a 
wide variety of agonists (19). Investigation of the receptor function was 
performed using a device containing 48 separate channels enabling the 
sequential exposure of a single cell to 48 different solutions, allowing the 
determination of several distinct dose response curves from the same cell using 
different agonists and antagonists with varying properties for the activation
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Fig. 1. Com ponents o f  the DF48 system. The microfluidic  ch ip  (bottom ) is con trolled  by 
a versatile software (top right)  and  integrates easily into an existing m icroscope se t-up  (top left).
kinetics of the receptor (Figure 2). The ion channels were activated by 
sequential exposure to seven different concentrations o f GABA and ß-alanine, 
respectively, followed by six different concentrations of the antagonist 
bicuculline, со-applied with 100 дМ  GABA. Due to the greater number of 
channels available it is possible to record complete dose response curves, for 
several different agonists, from the same cell. In this way, cell to cell variation is 
eliminated, producing better data quality along with the possibility to compare 
the effects of different agonists and antagonist more clearly, since the same cell 
is used throughout the recording. At the same time, the applied flow results in 
longer recording times and improved recording parameters.
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Fig . 2. M ultip le agonist app lication to the same cell. T hree d ifferent dose  response curves recorded  
from the same cell in one continuous trace. A lifted patch c lam ped W SS-1 cell expressing the 
GA BA a  recep tor was exposed to th ree differen t sets o f antagonist and /or agonist and the resulting 
current was recorded. L ow er part shows dose response curves obtained by p lo tting peak current 
versus concentration o f agonist o r antagonist (n=3).
Because of the rapid solution switching and complete control over 
solution environments various properties of different agonists can be resolved. 
To illustrate this, close-ups of the whole-cell currents induced by brief (100 ms) 
applications o f saturating concentrations o f GABA and ß-alanine respectively 
are shown (Figure 3). The onset of current is the same for both agonists whereas 
the more rapid unbinding o f ß-alanine (20,21) is clearly seen during the return to 
baseline phase, where the GABA induced current returns much slower as 
compared to the ß-alanine induced current. Thus, using the system described 
here to probe ion channel function, it is possible to resolve differences in 
unbinding rates of different ligands. The system has also previously been used 
successfully for extremely rapid ion channel systems such as AM PA/kainate, 
NMDA, and nicotinergic a7 ion channels, demonstrating the versatility o f the 
system with regards to experimental systems requiring high temporal resolution.
In conclusion, the Dynaflow1M 48 microfluidic system makes it possible 
to record a large number of dose response curves quickly, with the added benefit 
of producing longer recording times and lower noise levels. The described 
microfluidic chip system offers robust and reliable detection with major
Fig . 3. Differences in unbinding  rates are clearly resolved. C lose  up  o f  whole cell kinetics from 
G AB A a  receptors, induced by rap id application o f GABA (black trace) o r ß -a lanine (grey trace). 
The pronounced  difference in off-rate  between the two agonists is clearly  seen.
increases in throughput for conventional, high-quality patch-clamp screening of 
ion channel functions. Moreover, the 48 channel layout allows for several 
different agonists, antagonists or combinations thereof to be applied to the same 
cell, eliminating cell to cell variation. Data quality is improved by the fact that 
entire dose responses are easily obtained from the same patch-clamped cell and 
with increased signal-to-noise ratio due to the flow stabilization of the seal. In 
the long term, the Dynaflow IM 48 system offers the possibility of ion channel 
screening with maintained information content, increased throughput and 
decreased cost.
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